These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30043096)

  • 1. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.
    Alshaker H; Srivats S; Monteil D; Wang Q; Low CMR; Pchejetski D
    Breast Cancer Res Treat; 2018 Nov; 172(1):33-43. PubMed ID: 30043096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
    Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
    Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and evaluation of inhibitors of human sphingosine kinase.
    French KJ; Schrecengost RS; Lee BD; Zhuang Y; Smith SN; Eberly JL; Yun JK; Smith CD
    Cancer Res; 2003 Sep; 63(18):5962-9. PubMed ID: 14522923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
    Alshaker H; Wang Q; Srivats S; Chao Y; Cooper C; Pchejetski D
    Breast Cancer Res Treat; 2017 Oct; 165(3):531-543. PubMed ID: 28695300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).
    Aurelio L; Scullino CV; Pitman MR; Sexton A; Oliver V; Davies L; Rebello RJ; Furic L; Creek DJ; Pitson SM; Flynn BL
    J Med Chem; 2016 Feb; 59(3):965-84. PubMed ID: 26780304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase 1 (SK1) allosteric inhibitors that target the dimerization site.
    Bayraktar O; Ozkirimli E; Ulgen K
    Comput Biol Chem; 2017 Aug; 69():64-76. PubMed ID: 28587987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
    Antoon JW; White MD; Slaughter EM; Driver JL; Khalili HS; Elliott S; Smith CD; Burow ME; Beckman BS
    Cancer Biol Ther; 2011 Apr; 11(7):678-89. PubMed ID: 21307639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a sphingosine kinase 1 specific small-molecule inhibitor.
    Hengst JA; Wang X; Sk UH; Sharma AK; Amin S; Yun JK
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7498-502. PubMed ID: 21050755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel sphingosine kinase 1 inhibitors.
    Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).
    Bayraktar O; Ozkirimli E; Ulgen KO
    Curr Protein Pept Sci; 2018; 19(5):430-444. PubMed ID: 27829348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
    Ren S; Xin C; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase 1 as an anticancer therapeutic target.
    Gao Y; Gao F; Chen K; Tian ML; Zhao DL
    Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1.
    Alshaker H; Wang Q; Böhler T; Mills R; Winkler M; Arafat T; Kawano Y; Pchejetski D
    Sci Rep; 2017 Jun; 7(1):3493. PubMed ID: 28615679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
    Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
    Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of BODIPY-PF-543.
    Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
    Gao P; Peterson YK; Smith RA; Smith CD
    PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.
    Pchejetski D; Böhler T; Stebbing J; Waxman J
    Nat Rev Urol; 2011 Sep; 8(10):569-678. PubMed ID: 21912422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of selective inhibitors of sphingosine kinase 1.
    Baek DJ; MacRitchie N; Pyne NJ; Pyne S; Bittman R
    Chem Commun (Camb); 2013 Mar; 49(21):2136-8. PubMed ID: 23388656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.